Bromide in Patients with SCN1A-Mutations Manifesting as Dravet Syndrome-Reference-Cited by-同舟云学术

Bromide in Patients with SCN1A-Mutations Manifesting as Dravet Syndrome

Published:2012-02 Issue:01 Volume:43 Page:017-021
ISSN:0174-304X
Container-title:Neuropediatrics
language:en
Short-container-title:Neuropediatrics

Author:

Lotte Jan¹,Haberlandt Edda²,Neubauer Bernd³,Staudt Martin¹⁴,Kluger Gerhard¹⁵

Affiliation:

1. Neuropediatric Clinic and Clinic for Neurorehabilitation, Epilepsy Center for Children and Adolescents, Schön Klinik Vogtareuth, Germany

2. Clinical Department of Pediatrics IV, Division of Neonatology, Neuropediatrics and Inherited Metabolic Diseases, Medical University Innsbruck, Innsbruck, Austria

3. Zentrum für Kinderheilkunde und Jugendmedizin, Abteilunge für Neuropädiatrie und Sozialmedizin, Universitätsklinikum Gießen, Gießen, Germany

4. Department of Pediatric Neurology and Developmental Medicine, University Children's Hospital, Tübingen, Germany

5. Paracelsus Medical University, Salzburg, Austria

Publisher

Georg Thieme Verlag KG

Subject

Clinical Neurology,General Medicine,Pediatrics, Perinatology, and Child Health

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0032-1307454.pdf

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical heterogeneity of epilepsy and mutation spectrum of voltage-gated sodium channel genes;2024-01-02

2. Dravet syndrome: Advances in etiology, clinical presentation, and treatment;Epilepsy Research;2022-12

3. Kaliumbromid – auch heute noch ein wichtiges Antikonvulsivum;Kinder- und Jugendmedizin;2022-11

4. Neue Aspekte zur Therapie des Dravet-Syndroms;Kinder- und Jugendmedizin;2022-11

5. Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies;CNS Drugs;2022-10